Recent Finacing
Recent Raise
AgeX Therapeutics develops cell‑based regenerative therapies and iTR (induced Tissue Regeneration) targeting aging mechanisms—telomerase-mediated cell immortality, brown adipocytes, vascular progenitors—and genomics algorithms plus PSC-derived cardiomyocytes for drug screening.
Focus Areas
Recent Investors
Valuation as of 08/17/2017
Total Raised
Funding rounds
Investors
